LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.25 | 771.67 | 13358 | 11367 | 1.1751 | 1.0849 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.25 | 771.67 | 10351 | 11367 | 0.9106 | 0.9523 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 80.48 | 771.67 | 13719 | 11685 | 1.1741 | 1.0836 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 80.48 | 771.67 | 10525 | 11685 | 0.9007 | 0.9474 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.69 | 771.67 | 14115 | 11974 | 1.1788 | 1.0849 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 82.69 | 771.67 | 10572 | 11974 | 0.8829 | 0.9380 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.92 | 771.67 | 14379 | 12266 | 1.1722 | 1.0812 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 84.92 | 771.67 | 10614 | 12266 | 0.8653 | 0.9288 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.14 | 771.67 | 14769 | 12592 | 1.1728 | 1.0807 | MN20160304_L01 | I12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.14 | 771.67 | 10701 | 12592 | 0.8498 | 0.9208 | MN20160304_L01 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.49 | 771.67 | 826 | 867 | 0.9519 | 0.4947 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 2.49 | 771.67 | 822 | 867 | 0.9473 | 0.4524 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.71 | 771.67 | 909 | 956 | 0.9505 | 0.6973 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 4.71 | 771.67 | 891 | 956 | 0.9316 | 0.5911 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.94 | 771.67 | 1016 | 1045 | 0.9721 | 0.8749 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 6.94 | 771.67 | 992 | 1045 | 0.9492 | 0.7752 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 9.16 | 771.67 | 1103 | 1138 | 0.9688 | 0.8902 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 9.16 | 771.67 | 1058 | 1138 | 0.9293 | 0.7550 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 11.56 | 771.67 | 1226 | 1280 | 0.9574 | 0.8842 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 11.56 | 771.67 | 1238 | 1280 | 0.9667 | 0.9095 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 13.78 | 771.67 | 1385 | 1459 | 0.9488 | 0.8889 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 13.78 | 771.67 | 1397 | 1459 | 0.9570 | 0.9067 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.00 | 771.67 | 1525 | 1585 | 0.9618 | 0.9265 | MN20160304_L01 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 16.00 | 771.67 | 1562 | 1585 | 0.9852 | 0.9715 | MN20160304_L01 | D12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 18.22 | 771.67 | 1693 | 1741 | 0.9722 | 0.9526 | MN20160304_L01 | C19 |